PNPLA3 and metabolic dysfunction-associated steatohepatitis: In contrast, patients with NASH significantly more frequently harbored the PNPLA3 G allele variant [69.4% vs. 39.1% (p = 0.03)] and MBOAT7-TMC4 A allele variant [75% vs. 42.1% (p = 0.03)].